News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
615,897 Results
Type
Article (44853)
Company Profile (347)
Press Release (570697)
Section
Business (177049)
Career Advice (2550)
Deals (32116)
Drug Delivery (99)
Drug Development (79930)
Employer Resources (153)
FDA (15063)
Job Trends (13476)
News (310425)
Policy (30325)
Tag
Academia (2719)
Alliances (44325)
Alzheimer's disease (1295)
Approvals (14978)
Artificial intelligence (132)
Bankruptcy (326)
Best Places to Work (10916)
Biotechnology (273)
Breast cancer (121)
Cancer (1066)
Cardiovascular disease (94)
Career advice (2145)
Cell therapy (240)
Clinical research (63121)
Collaboration (365)
Compensation (143)
COVID-19 (2581)
C-suite (97)
Data (1050)
Diabetes (154)
Diagnostics (5823)
Drug pricing (89)
Earnings (65785)
Employer resources (139)
Events (91764)
Executive appointments (288)
FDA (15560)
Funding (338)
Gene therapy (187)
GLP-1 (626)
Government (4409)
Healthcare (17838)
Infectious disease (2666)
Inflammatory bowel disease (116)
Interviews (530)
IPO (14761)
Job creations (2927)
Job search strategy (1773)
Layoffs (417)
Legal (6670)
Lung cancer (178)
Manufacturing (169)
Medical device (11716)
Medtech (11720)
Mergers & acquisitions (17411)
Metabolic disorders (421)
Neuroscience (1573)
NextGen Class of 2024 (6204)
Non-profit (4239)
Northern California (1346)
Obesity (242)
Opinion (222)
Patents (101)
People (54805)
Phase I (19687)
Phase II (27849)
Phase III (20806)
Pipeline (442)
Postmarket research (2473)
Preclinical (8393)
Radiopharmaceuticals (246)
Rare diseases (223)
Real estate (4762)
Regulatory (20550)
Research institute (2337)
Resumes & cover letters (379)
Southern California (1233)
Startups (3283)
United States (12391)
Vaccines (555)
Weight loss (193)
Date
Today (160)
Last 7 days (886)
Last 30 days (3549)
Last 365 days (34737)
2024 (31414)
2023 (38548)
2022 (49557)
2021 (53524)
2020 (51791)
2019 (44223)
2018 (33369)
2017 (31015)
2016 (29715)
2015 (34763)
2014 (27001)
2013 (22092)
2012 (23421)
2011 (24303)
2010 (21997)
Location
Africa (786)
Arizona (143)
Asia (38374)
Australia (7330)
California (3064)
Canada (1203)
China (232)
Colorado (138)
Connecticut (134)
Europe (84024)
Florida (411)
Georgia (103)
Illinois (312)
Indiana (185)
Kansas (89)
Maryland (561)
Massachusetts (2409)
Michigan (145)
Minnesota (239)
New Jersey (889)
New York (893)
North Carolina (691)
Northern California (1346)
Ohio (126)
Pennsylvania (737)
South America (1093)
Southern California (1233)
Texas (407)
Washington State (333)
615,897 Results for "prescient therapeutics formerly known as virax holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Prescient Healthcare Group Appoints Two New Members to its Board of Directors
Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient’s global mission.
April 19, 2024
·
3 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
Business
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.
April 19, 2023
·
4 min read
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, announced that an 1 for 5 reverse split of its authorized share capital, was approved by the Company’s board of directors on May 29, 2023 and will become effective on June 21, 2024.
June 18, 2024
·
4 min read
Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study
Virax Biolabs Group Limited announced today the initiation of its Virax Immune COVID-19 Analytical Performance Study scheduled to take place through Q4 of this year.
October 26, 2022
·
4 min read
Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities
Virax Biolabs Group Limited, an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced that it has signed contracts to launch two new research and laboratory facilities in the United Kingdom.
July 18, 2023
·
6 min read
Drug Development
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate
Formerly known as AbGenomics Holding, AltruBio on Tuesday said it will use the funds to push its ulcerative colitis asset into a Phase IIb trial with an anticipated readout in 2026.
May 21, 2024
·
2 min read
·
Tyler Patchen
Business
Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of an Avian Influenza A Virus (“AIV”) real-time PCR test kit to markets accepting the CE mark, namely the European Union.
March 7, 2023
·
4 min read
Business
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.
Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX) announced today that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings Inc. (Nasdaq: COSM) (“Cosmos”).
September 22, 2022
·
4 min read
Business
Virax Biolabs’ CEO James Foster Issues Letter to Shareholders
Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), today announced that Mr. James Foster , Chief Executive Officer of Virax, has issued a letter to shareholders.
February 2, 2023
·
9 min read
1 of 61,590
Next
